MAM
VRTX icon

Madison Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Madison Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
29,302
+1,915
+7% +$849K 0.17% 119
2026
Q1 		$12.2M Buy
27,387
+10,952
+67% +$5.11M 0.15% 126
2025
Q4 		$7.45M Buy
16,435
+234
+1% +$101K 0.09% 146
2025
Q3 		$6.34M Buy
16,201
+2,009
+14% +$840K 0.07% 152
2025
Q2 		$6.32M Sell
14,192
-204
-1% -$94K 0.07% 155
2025
Q1 		$6.98M Sell
14,396
-126
-0.9% -$58.7K 0.08% 147
2024
Q4 		$5.85M Buy
14,522
+11
+0.1% +$5.1K 0.07% 157
2024
Q3 		$6.75M Sell
14,511
-129
-0.9% -$62K 0.08% 154
2024
Q2 		$6.86M Buy
14,640
+8
+0.1% +$3.47K 0.08% 151
2024
Q1 		$6.12M Sell
14,632
-44
-0.3% -$18.6K 0.08% 159
2023
Q4 		$5.97M Sell
14,676
-338
-2% -$125K 0.08% 162
2023
Q3 		$5.22M Sell
15,014
-213
-1% -$74.5K 0.08% 161
2023
Q2 		$5.36M Sell
15,227
-314
-2% -$106K 0.08% 160
2023
Q1 		$4.9M Sell
15,541
-284
-2% -$85.2K 0.07% 167
2022
Q4 		$4.57M Buy
15,825
+78
+0.5% +$23.8K 0.07% 174
2022
Q3 		$4.56M Buy
15,747
+181
+1% +$52.1K 0.08% 165
2022
Q2 		$4.39M Buy
15,566
+72
+0.5% +$19.3K 0.07% 173
2022
Q1 		$4.04M Buy
15,494
+766
+5% +$182K 0.06% 193
2021
Q4 		$3.23M Sell
14,728
-403
-3% -$78.4K 0.04% 230
2021
Q3 		$2.75M Buy
15,131
+763
+5% +$149K 0.04% 245
2021
Q2 		$2.9M Buy
14,368
+10,533
+275% +$2.2M 0.04% 248
2021
Q1 		$824K Buy
3,835
+435
+13% +$95.5K 0.01% 269
2020
Q4 		$804K Buy
3,400
+400
+13% +$91.8K 0.01% 258
2020
Q3 		$816K Hold
3,000
– – 0.01% 229
2020
Q2 		$871K Hold
3,000
– – 0.02% 230
2020
Q1 		$714K Hold
3,000
– – 0.01% 225
2019
Q4 		$657K Buy
+3,000
New +$607K 0.01% 252

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Madison Asset Management's VRTX Position: Q2 2026 in Review

Madison Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 7% in Q2 2026, buying an estimated $849K and bringing the position to 29,302 shares worth $14.6M. The position accounts for 0.17% of the portfolio, ranked #119.

Madison Asset Management first reported a position in VRTX in Q4 2019 and has held it in 27 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Madison Asset Management held 29,302 shares of Vertex Pharmaceuticals worth $14.6M as of Q2 2026.
  • Madison Asset Management bought 1,915 Vertex Pharmaceuticals shares in Q2 2026, an estimated $849K.
  • Vertex Pharmaceuticals made up 0.17% of Madison Asset Management's portfolio in Q2 2026, its #119 holding.
  • Madison Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.